Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Butterfly Network
BFLY
$1.86B
| – | – |
-48,593
| Closed | -$57.6K |
|
2552
Blink Charging
BLNK
$67.5M
| – | – |
-17,583
| Closed | -$53.7K |
|
|
BLUE
2553
DELISTED
bluebird bio
BLUE
| – | – |
-2,030
| Closed | -$123K |
|
2554
DMC Global
BOOM
$111M
| – | – |
-8,239
| Closed | -$202K |
|
2555
Baytex Energy
BTE
$2.96B
| – | – |
-400,000
| Closed | -$1.77M |
|
2556
Babcock & Wilcox
BW
$1.18B
| – | – |
-27,451
| Closed | -$116K |
|
2557
CareDx
CDNA
$1.83B
| – | – |
-23,653
| Closed | -$165K |
|
2558
Cerus
CERS
$575M
| – | – |
-77,250
| Closed | -$125K |
|
2559
CI&T Inc
CINT
$423M
| – | – |
-13,550
| Closed | -$88K |
|
2560
Clarus
CLAR
$125M
| – | – |
-10,197
| Closed | -$77.1K |
|
2561
Emergent Biosolutions
EBS
$379M
| – | – |
-20,359
| Closed | -$69.3K |
|
2562
8x8 Inc
EGHT
$279M
| – | – |
-47,012
| Closed | -$118K |
|
2563
Evolution Petroleum
EPM
$133M
| – | – |
-12,767
| Closed | -$87.3K |
|
2564
EVgo
EVGO
$219M
| – | – |
-31,765
| Closed | -$108K |
|
2565
Expensify
EXFY
$174M
| – | – |
-21,545
| Closed | -$69.9K |
|
2566
Fate Therapeutics
FATE
$275M
| – | – |
-33,963
| Closed | -$72.2K |
|
2567
Future Fuel
FF
$205M
| – | – |
-11,160
| Closed | -$80K |
|
2568
Monte Rosa Therapeutics
GLUE
$1.82B
| – | – |
-23,743
| Closed | -$114K |
|
|
ISPO
2569
DELISTED
Inspirato
ISPO
| – | – |
-72,031
| Closed | -$850K |
|
|
ITOS
2570
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-500,324
| Closed | -$5.48M |
|
2571
Klaviyo
KVYO
$5.8B
| – | – |
-500,018
| Closed | -$17.3M |
|
2572
LivePerson
LPSN
$22M
| – | – |
-1,907
| Closed | -$111K |
|
|
CYPH
2573
Cypherpunk Technologies Inc
CYPH
$64M
| – | – |
-358,060
| Closed | -$423K |
|
2574
Luxfer Holdings
LXFR
$456M
| – | – |
-12,128
| Closed | -$158K |
|
2575
Lexicon Pharmaceuticals
LXRX
$1.03B
| – | – |
-29,470
| Closed | -$32K |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.